Trial intelligence / Profile preview

Anifrolumab for Lupus Fatigue: Functional MRI Application in SLE (ALFA-SLE)

jRCTs011250076Recruiting

Sponsor
Hokkaido University Hospital
Start
Jul 2026
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Open-label, single-arm trial of anifrolumab in systemic lupus erythematosus (SLE), sponsored by Hokkaido University Hospital. Started Jul 2026; status: recruiting.

02

Drugs

anifrolumab
03

Conditions

systemic lupus erythematosus (SLE)

Beyond the preview

Go deeper on jRCTs011250076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs011250076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call